These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21167710)

  • 1. Structure-activity relationships of trans-substituted-propenoic acid derivatives on the nicotinic acid receptor HCA2 (GPR109A).
    van Veldhoven JP; Blad CC; Artsen CM; Klopman C; Wolfram DR; Abdelkadir MJ; Lane JR; Brussee J; Ijzerman AP
    Bioorg Med Chem Lett; 2011 May; 21(9):2736-9. PubMed ID: 21167710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of determinants of ligand binding to the nicotinic acid receptor GPR109A (HM74A/PUMA-G).
    Tunaru S; Lättig J; Kero J; Krause G; Offermanns S
    Mol Pharmacol; 2005 Nov; 68(5):1271-80. PubMed ID: 16099840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular modeling aided design of nicotinic acid receptor GPR109A agonists.
    Deng Q; Frie JL; Marley DM; Beresis RT; Ren N; Cai TQ; Taggart AK; Cheng K; Carballo-Jane E; Wang J; Tong X; Waters MG; Tata JR; Colletti SL
    Bioorg Med Chem Lett; 2008 Sep; 18(18):4963-7. PubMed ID: 18760600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorinated pyrazole acids are agonists of the high affinity niacin receptor GPR109a.
    Skinner PJ; Cherrier MC; Webb PJ; Shin YJ; Gharbaoui T; Lindstrom A; Hong V; Tamura SY; Dang HT; Pride CC; Chen R; Richman JG; Connolly DT; Semple G
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5620-3. PubMed ID: 17804224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonist lead identification for the high affinity niacin receptor GPR109a.
    Gharbaoui T; Skinner PJ; Shin YJ; Averbuj C; Jung JK; Johnson BR; Duong T; Decaire M; Uy J; Cherrier MC; Webb PJ; Tamura SY; Zou N; Rodriguez N; Boatman PD; Sage CR; Lindstrom A; Xu J; Schrader TO; Smith BM; Chen R; Richman JG; Connolly DT; Colletti SL; Tata JR; Semple G
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4914-9. PubMed ID: 17588745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-Alkyl-benzotriazole-5-carboxylic acids are highly selective agonists of the human orphan G-protein-coupled receptor GPR109b.
    Semple G; Skinner PJ; Cherrier MC; Webb PJ; Sage CR; Tamura SY; Chen R; Richman JG; Connolly DT
    J Med Chem; 2006 Feb; 49(4):1227-30. PubMed ID: 16480258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of pyrazolopyrimidines as the first class of allosteric agonists for the high affinity nicotinic acid receptor GPR109A.
    Shen HC; Taggart AK; Wilsie LC; Waters MG; Hammond ML; Tata JR; Colletti SL
    Bioorg Med Chem Lett; 2008 Sep; 18(18):4948-51. PubMed ID: 18752940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
    Kawasuji T; Yoshinaga T; Sato A; Yodo M; Fujiwara T; Kiyama R
    Bioorg Med Chem; 2006 Dec; 14(24):8430-45. PubMed ID: 17010623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrazole derivatives as partial agonists for the nicotinic acid receptor.
    van Herk T; Brussee J; van den Nieuwendijk AM; van der Klein PA; IJzerman AP; Stannek C; Burmeister A; Lorenzen A
    J Med Chem; 2003 Aug; 46(18):3945-51. PubMed ID: 12930155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of (E)-2-(acrylamido)cyclohex-1-enecarboxylic acid derivatives as HCA1, HCA2, and HCA3 receptor agonists.
    Bobileva O; Bokaldere R; Gailite V; Kaula I; Ikaunieks M; Duburs G; Petrovska R; Mandrika I; Klovins J; Loza E
    Bioorg Med Chem; 2014 Jul; 22(14):3654-69. PubMed ID: 24864041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of pyrazolyl propionyl cyclohexenamide derivatives as full agonists for the high affinity niacin receptor GPR109A.
    Ding FX; Shen HC; Wilsie LC; Krsmanovic ML; Taggart AK; Ren N; Cai TQ; Wang J; Tong X; Holt TG; Chen Q; Waters MG; Hammond ML; Tata JR; Colletti SL
    Bioorg Med Chem Lett; 2010 Jun; 20(11):3372-5. PubMed ID: 20452209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships study of two series of leukotriene B4 antagonists: novel indolyl and naphthyl compounds substituted with a 2-[methyl(2-phenethyl)amino]-2-oxoethyl side chain.
    Chan WK; Huang FC; Morrissette MM; Warus JD; Moriarty KJ; Galemmo RA; Dankulich WD; Poli G; Sutherland CA
    J Med Chem; 1996 Sep; 39(19):3756-68. PubMed ID: 8809164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinity and kinetics study of anthranilic acids as HCA2 receptor agonists.
    van Veldhoven JP; Liu R; Thee SA; Wouters Y; Verhoork SJ; Mooiman C; Louvel J; IJzerman AP
    Bioorg Med Chem; 2015 Jul; 23(14):4013-25. PubMed ID: 25737085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-Nitro-4-amino benzoic acids and 6-amino nicotinic acids are highly selective agonists of GPR109b.
    Skinner PJ; Cherrier MC; Webb PJ; Sage CR; Dang HT; Pride CC; Chen R; Tamura SY; Richman JG; Connolly DT; Semple G
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6619-22. PubMed ID: 17931863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target.
    Offermanns S
    Trends Pharmacol Sci; 2006 Jul; 27(7):384-90. PubMed ID: 16766048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of orally bioavailable and novel urea agonists of the high affinity niacin receptor GPR109A.
    Shen HC; Szymonifka MJ; Kharbanda D; Deng Q; Carballo-Jane E; Wu KK; Wu TJ; Cheng K; Ren N; Cai TQ; Taggart AK; Wang J; Tong X; Waters MG; Hammond ML; Tata JR; Colletti SL
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6723-8. PubMed ID: 18029181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel 3,6,7-substituted pyrazolopyrimidines as positive allosteric modulators for the hydroxycarboxylic acid receptor 2 (GPR109A).
    Blad CC; van Veldhoven JP; Klopman C; Wolfram DR; Brussee J; Lane JR; Ijzerman AP
    J Med Chem; 2012 Apr; 55(7):3563-7. PubMed ID: 22420767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPR109a agonists. Part 2: pyrazole-acids as agonists of the human orphan G-protein coupled receptor GPR109a.
    Imbriglio JE; Chang S; Liang R; Raghavan S; Schmidt D; Smenton A; Tria S; Schrader TO; Jung JK; Esser C; Holt TG; Wolff MS; Taggart AK; Cheng K; Carballo-Jane E; Waters MG; Tata JR; Colletti SL
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4472-4. PubMed ID: 20615702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The psoriasis drug monomethylfumarate is a potent nicotinic acid receptor agonist.
    Tang H; Lu JY; Zheng X; Yang Y; Reagan JD
    Biochem Biophys Res Commun; 2008 Oct; 375(4):562-5. PubMed ID: 18722346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of HCA₂ (GPR109A) in nicotinic acid and fumaric acid ester-induced effects on the skin.
    Hanson J; Gille A; Offermanns S
    Pharmacol Ther; 2012 Oct; 136(1):1-7. PubMed ID: 22743741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.